RUA — Rua Bioscience Balance Sheet
0.000.00%
- NZ$11.63m
- NZ$12.12m
- NZ$1.51m
- 26
- 29
- 80
- 42
Annual balance sheet for Rua Bioscience, fiscal year end - June 30th, NZD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 16.4 | 9.94 | 4.56 | 0.895 | 0.241 |
Net Total Receivables | 0.606 | 1.07 | 0.863 | 0.277 | 0.357 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 17.1 | 11.4 | 5.6 | 2.82 | 2.3 |
Net Property, Plant And Equipment | 7.1 | 6.64 | 4.54 | 2.65 | 2.21 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 30.9 | 33.6 | 21 | 7.74 | 6.77 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.18 | 4.86 | 0.762 | 0.874 | 1.84 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.02 | 9.38 | 0.83 | 0.973 | 1.88 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 28.8 | 24.2 | 20.1 | 6.77 | 4.89 |
Total Liabilities & Shareholders' Equity | 30.9 | 33.6 | 21 | 7.74 | 6.77 |
Total Common Shares Outstanding |